Location: Home
  • search
  • go
  • Relate News
  • 9/11/2013GSK Denies Rumors for Quiting China amid Looming U.S. Investigation
  • 9/11/2013Expert: MNCs in China Worried over Compliance Risks
  • 9/11/2013Huahai Lines Up with AMMS for CNS Drug R&D
  • 9/11/2013Hisun Pharmaceutical Receives Clinical Trial Approval for Ginsenoside ...
  • 9/11/2013Gan & Lee Pharma Drawn into Corruption Scandal by Whistleblower
  • 9/10/2013Thinking Through the GSK Scandal
  • 9/10/2013Luqa Pharma and Stratpharma extend their collaboration in China
  • 9/9/2013NDRC Official Responds to Imported Drug Pricing Comparison Claims
  • 9/9/2013State Council Sends Out Inspectors to Supervise Healthcare Reform at t...
  • 9/6/2013China is Committed to Fully Implementing Electronic Drug Regulation by...
  • 9/6/2013Healthcare Sector Remains a Hotspot for VC/PE
  • 9/6/2013Nine Chinese Pharma Distributor Form Joint Laboratory for Temperature ...
  • 9/6/2013Sales Expenditures of Listed Chinese Pharma Companies Remained High in...
  • 9/6/2013Forbes: BGI Headed for IPO of Its Institutional Business
  • 9/6/2013Updated - GlaxoSmithKline Considers Quitting China?
  • 9/6/2013EU Group Claims Unfair Treatment of Foreign Companies in China's Corru...
  • 9/6/2013Executive Moves
  • 9/6/2013China Plans "Astronomical" Fines on GSK for Corruption
  • 9/6/2013Vesale, Hainan Honz Enter Probiotic Distribution Deal
  • 9/4/2013Shanghai Maintains Existing Local Essential Drug Supplement List
  • 9/4/2013China Warned of A Major Epidemic of Diabetes-related Complications
  • 9/4/2013Three Ways To Understand GSK's China Scandal (External)
  • 9/4/2013Syndax, EddingPharm Enter Agreement to Sell Cancer Drug in China and C...
  • 9/3/2013IMS: Formulated TCMs Accounted One Third of Chinese Pharmaceutical Mar...
  • 9/3/2013IMS Health: China Pharmaceutical Market Snapshot in Q1/2013
  • 9/3/2013Acebright to Invest US$1M into Israel's NasVax
  • 9/3/2013Merck Renews China Sales Agreement with Zhifei Bio for Vaccines
  • 9/2/2013Chinese Police Reveals More Details of GSK China Corruption
  • 9/2/2013Chinese Biopharma Outsourcing Market to Grow 30% CAGR before 2018
  • 9/2/2013Ipsen China Sales "Affected" amid Expanding Pharma Probe
  • Page:496/774 Total number of articles:23207: [First][<<] [494] [495] [496] [497] [498] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group